Sonoma Pharmaceuticals (SNOA) said late Tuesday that its hypochlorous acid-based acne products will be
sold through a health and beauty retailer and pharmacy chain in the United Kingdom.
The company said the move follows registration of its hypochlorous acid-based acne products with the UK's Medicines & Healthcare products Regulatory Agency.
Shares of the company surged 77% in premarket activity early Wednesday.
It said the "prominent" UK pharmacy chain has over 1,200 stores.
The product line includes an acne toner and a balancing serum.
Price: 4.12, Change: +1.79, Percent Change: +76.82
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.